Perspective Therapeutics (CATX) Total Debt (2023 - 2026)

Perspective Therapeutics has disclosed Total Debt across 4 years of filings, most recently posting $1.6 million for Q2 2026.

• In Q2 2026, Total Debt fell 3.27% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (down 3.27% YoY), while the FY2025 annual figure was $1.6 million, down 3.1% from the prior year.
• Total Debt came in at $1.6 million for Q2 2026 at Perspective Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $1.9 million in Q1 2023 to a low of $1.6 million in Q2 2026.
• Average Total Debt over 4 years is $1.7 million, with a median of $1.7 million recorded in 2024.
• The largest YoY upside for Total Debt was 2.78% in 2024 against a maximum downside of 8.54% in 2024.
• Over 4 years, Total Debt stood at $1.7 million in 2023, then fell by 2.78% to $1.7 million in 2024, then declined by 3.1% to $1.6 million in 2025, then slipped by 1.72% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $1.6 million in Q2 2026, $1.6 million in Q1 2026, and $1.6 million in Q4 2025.